,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destiny-breast04']
standing ovation to the destiny-breast04 trial #asco22.
the future of breast- oncology!!! 
Addressing cancer health care disparities, one person at a time.
Prospecting Hematology/Oncology Fellow come 2023